Why Did ReShape Lifesciences Plunge 22.67% After Stock Split?

On May 12, 2025, ReShape Lifesciences experienced a significant drop of 22.67% in pre-market trading, marking a notable decline in its stock performance.

ReShape Lifesciences recently announced a stock split with a ratio of 1:25, which is expected to impact the company's share price and trading volume. This move is part of the company's strategy to make its shares more accessible to a broader range of investors.

The company's stock has been under scrutiny due to its short interest ratio, which reflects the percentage of shares that have been sold short compared to the total number of shares outstanding. This metric is often used by investors to gauge market sentiment and potential volatility in the stock.